In line with a positive role in cell differentiation and/or apoptosis, increased ERBB4 expression was found associated with longer relapse-free survival (15–17), disease-free survival (17, 18), and overall survival (15, 17–20) in breast cancer patients [reviewed in (13, 21)]. This evidence concerns the gene ERBB4 and breast cancer.